OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by ...

President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC ...

Though Altman said he likely wouldn’t agree with Trump on “everything,” the OpenAI CEO said he believes “he will be ...

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

The tech world is abuzz as two of its most prominent figures, Elon Musk and Sam Altman, have taken to social media to air ...

OpenAI, led by CEO Sam Altman, is backing an initiative known as AI 2030, which is aimed at shaping "public dialogue about U.S. competition against China on AI," Politico reported in October.

Sam Altman, CEO of OpenAI, announced that AGI has not yet been achieved and the company plans to release new developments next month. He cautioned against high expectations fueled by social media ...

The company is making a foray into scientific discovery with an AI built to help manufacture stem cells. When you think of AI’s contributions to science, you probably think of AlphaFold, the ...

Sam Altman has shut down online "hype" after rumors the company had achieved AGI behind closed doors went viral on X. OpenAI CEO Sam Altman is trying to calm the online hype surrounding his company.

OpenAI, led by CEO Sam Altman, is backing an initiative known as AI 2030, which is aimed at shaping "public dialogue about U.S. competition against China on AI," Politico reported in October. The ...